Skip Navigation

Publication Detail

Title: Cyclooxygenase-2 is involved in HIV-1 Tat-induced inflammatory responses in the brain.

Authors: Flora, Govinder; Pu, Hong; Hennig, Bernhard; Toborek, Michal

Published In Neuromolecular Med, (2006)

Abstract: Cyclooxygenase (COX)-2, a rate-limiting enzyme for prostanoid synthesis, can be involved in inflammatory-mediated cytotoxicity. Although the contribution of COX-2 to peripheral inflammation is well understood, its role in brain inflammation is not fully recognized. In particular, COX-2 involvement in inflammatory responses induced by HIV proteins in the central nervous system is not known. Therefore, the present study focused on COX-2 expression and its role in modulating the expression of brain inflammatory-related genes following exposure to the HIV-1 transactivating protein Tat. Intrahippocampal injections of Tat induced dose-dependent upregulation of COX-2 mRNA and protein levels in C57BL/6 mice. COX-2 immunoreactivity was primarily localized in microglial cells and astrocytes. Tat-induced COX-2 expression was partially prevented by pyrrolidine dithiocarbamate, a potent antioxidant and an inhibitor of the transcription factor, nuclear factor kappaB. Most importantly, administration of the COX-2 inhibitor NS-398 attenuated Tat-mediated upregulation of mRNA and protein expression of inflammatory mediators, such as monocyte chemoattractant protein-1, interleukin-1beta, tumor necrosis factor-alpha, and inducible nitric oxide synthase. Moreover, treatment with NS-398 significantly attenuated Tat-induced activation of microglial cells. These results provide evidence that COX-2 overexpression can modulate induction of brain inflammatory mediators in response to HIV-1 Tat protein. Such alterations may play an important role in the development of brain inflammatory reactions in HIV-infected patients and contribute to the development of neurological complications in the course of HIV-1 infection.

PubMed ID: 16775385 Exiting the NIEHS site

MeSH Terms: Animals; Astrocytes/cytology; Astrocytes/metabolism; Brain*/enzymology; Brain*/immunology; Cyclooxygenase 2/genetics; Cyclooxygenase 2/metabolism*; Cyclooxygenase Inhibitors/metabolism; Dose-Response Relationship, Immunologic; Gene Expression Regulation, Enzymologic; Gene Products, tat/immunology*; HIV-1/immunology*; Humans; Inflammation/metabolism*; Male; Mice; Mice, Inbred C57BL; Microglia/cytology; Microglia/metabolism; NF-kappa B/metabolism; Nitrobenzenes/metabolism; Oxidation-Reduction; RNA, Messenger/metabolism; Sulfonamides/metabolism; tat Gene Products, Human Immunodeficiency Virus

Back
to Top